Global

Dec 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
Dec 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Spain's leading business school, IESE, organized an expert conference on October 2-3 to address two simple questions. First, how can providers and payers work together to generate more value from existing resources? Second, what must be done to ensure the system continues to create value in the first place?
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
For the second time in recent memory, a top European regulator leaves office abruptly and under a cloud of suspicion.
Oct 01, 2012
Pharmaceutical Executive
The new head of EFPIA faces a Promethean challenge: selling the merits of costly science and innovation in an era of bristling competition, fiscal crisis, and declining demographics.
Oct 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The Brazilian government's policy on biologics doesn't adequately address non-biologic complex drugs. Additional guidance is needed to bring these important medicines to market.
Sep 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Europe's fiscal crisis is becoming a new rallying cry for patient groups—but regional unity is still elusive.
May 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Will changes to the P&R system in the UK finally put some real metrics behind the elusive concept of value?
Apr 02, 2012
By Pharmaceutical Executive Editors
Pharm Exec talks to Carlos Plata, Chief Scientific Officer of Esteve, the Spanish company that is rising above the economic gloom to become a major player in pain.
native1_300x100
lorem ipsum